Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.99 USD | -0.33% | +0.02% | -12.48% |
20/05 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
14/05 | Transcript : Exelixis, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:35 PM |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.48% | 6.13B | |
+9.58% | 115B | |
+13.30% | 107B | |
-13.70% | 22.31B | |
-3.76% | 21.6B | |
-5.71% | 18.23B | |
-38.57% | 17.62B | |
+7.57% | 14.26B | |
+34.58% | 12.37B | |
-27.17% | 8.28B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Transcript : Exelixis, Inc., Q1 2024 Earnings Call, Apr 30, 2024